Rebastinib (DCC-2036)
Product Specifications
CAS Number
1020172-07-9
Target
Bcr-Abl
Applications
Protein Tyrosine Kinase
Smiles
CC (C) (C) C1=NN (C (=C1) NC (=O) NC2=C (C=C (C=C2) OC3=CC (=NC=C3) C (=O) NC) F) C4=CC5=C (C=C4) N=CC=C5
Molecular Formula
C30H28FN7O3
Additionnal Information
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1 (WT) and Abl1 (T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC043136-100 1x 100 µL
Langerin / CD207 (Marker of Langerhans Cells) (LGRN/3136R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY400849 100 µg
MAD2 (MAD2L1) (NM_002358) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC470200-100 1x 100 µL
MHC II (HLA-DQ) (SPV-L3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details